Published in J Stroke Cerebrovasc Dis on October 01, 2007
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 3.36
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation (2002) 2.71
The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J Am Coll Cardiol (2008) 2.38
Comprehensive stroke centers overcome the weekend versus weekday gap in stroke treatment and mortality. Stroke (2011) 2.01
Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86
Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation (2008) 1.84
Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Stroke (2006) 1.80
Still no closure on the question of PFO closure. N Engl J Med (2013) 1.64
Optical bedside monitoring of cerebral blood flow in acute ischemic stroke patients during head-of-bed manipulation. Stroke (2014) 1.62
Sulfonylurea use before stroke does not influence outcome. Stroke (2011) 1.60
Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke (2009) 1.56
CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch. Stroke (2007) 1.55
Middle cerebral artery vasospasm: transcranial color-coded duplex sonography versus conventional nonimaging transcranial Doppler sonography. Crit Care Med (2009) 1.53
Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke (2003) 1.51
Brain hypoxia is associated with short-term outcome after severe traumatic brain injury independently of intracranial hypertension and low cerebral perfusion pressure. Neurosurgery (2011) 1.51
Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis (2003) 1.49
Transcranial optical monitoring of cerebrovascular hemodynamics in acute stroke patients. Opt Express (2009) 1.46
Paracetamol for stroke: easy in practice, but not in trials. Lancet Neurol (2009) 1.41
Headache as a risk factor for neurovascular events in pediatric brain tumor patients. Neurology (2013) 1.41
Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care (2009) 1.40
Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke (2008) 1.38
Carotid artery diameter in men and women and the relation to body and neck size. Stroke (2006) 1.35
Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32
CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage. J Neurosci (2014) 1.31
Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample. J Am Heart Assoc (2013) 1.22
Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke (2012) 1.18
Altered hemodynamics and regional cerebral blood flow in patients with hemodynamically significant stenoses. Stroke (2005) 1.14
ABC/XYZ estimates intracerebral hemorrhage volume as a percent of total brain volume in children. Stroke (2010) 1.13
Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve (2004) 1.12
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. Am Heart J (2013) 1.12
Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann Neurol (2011) 1.11
Disparities in evaluation at certified primary stroke centers: reasons for geographic and racial differences in stroke. Stroke (2013) 1.11
Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09
Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial. Stroke (2013) 1.08
Dialysis disequilibrium: another reversible posterior leukoencephalopathy syndrome? Clin Neurol Neurosurg (2003) 1.08
American Academy of Neurology replies to Jeanne Lenzer. BMJ (2013) 1.07
Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci (2003) 1.05
Control of the oscillator strength of the exciton in a single InGaN-GaN quantum dot. Phys Rev Lett (2007) 1.05
Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging (2009) 1.04
A comparison of Computed Tomography perfusion-guided and time-guided endovascular treatments for patients with acute ischemic stroke. Stroke (2010) 1.03
Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Stroke (2009) 1.01
Obstructive hydrocephalus from venous sinus thrombosis. Neurocrit Care (2009) 1.01
Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke (2008) 1.00
Bow hunter's syndrome caused by accessory cervical ossification: posterolateral decompression and the use of intraoperative Doppler ultrasonography. Surg Neurol (2006) 1.00
Neutrophil depletion diminishes monocyte infiltration and improves functional outcome after experimental intracerebral hemorrhage. Acta Neurochir Suppl (2011) 0.99
Who will consent to emergency treatment trials for subarachnoid hemorrhage? Acad Emerg Med (2009) 0.95
Pseudo-subarachnoid hemorrhage: report of three cases and review of the literature. Neurocrit Care (2004) 0.93
Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage. Neurocrit Care (2007) 0.92
D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification. J Stroke Cerebrovasc Dis (2009) 0.92
Autologous blood injection to model spontaneous intracerebral hemorrhage in mice. J Vis Exp (2011) 0.91
Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort. Front Neurol (2012) 0.91
Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale. Arch Neurol (2004) 0.90
Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Crit Care Med (2004) 0.90
Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke (2012) 0.90
A case of Powassan viral hemorrhagic encephalitis involving bilateral thalami. Clin Neurol Neurosurg (2011) 0.88
Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes (2012) 0.88
Initial experience in establishing an academic neuroendovascular service: program building, procedural types, and outcomes. J Neuroimaging (2008) 0.87
Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke (2009) 0.87
Treatment of intracranial arterial stenosis. Expert Rev Neurother (2006) 0.87
Tibial tuberosity advancement for stabilization of the canine cranial cruciate ligament-deficient stifle joint: surgical technique, early results, and complications in 101 dogs. Vet Surg (2007) 0.87
Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Circulation (2008) 0.87
Hemorrhagic transformation of childhood arterial ischemic stroke. Stroke (2011) 0.86
Fatal subacute cytomegalovirus encephalitis associated with hypogammaglobulinemia and thymoma. Mayo Clin Proc (2003) 0.86
Ischemic strokes after cardiac catheterization: opportune thrombolysis candidates? Arch Neurol (2006) 0.86
Agreement in endovascular thrombolysis patient selection based on interpretation of presenting CT and CT-P changes in ischemic stroke patients. Neurocrit Care (2012) 0.86
High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis. Neurosurgery (2011) 0.85
Intracranial angioplasty and/or stent placement in octogenarians is associated with a threefold greater risk of periprocedural stroke or death. J Endovasc Ther (2010) 0.85
Comparison of time to treatment between intravenous and endovascular thrombolytic treatments for acute ischemic stroke. J Vasc Interv Neurol (2011) 0.85
Seizures do not increase in-hospital mortality after intracerebral hemorrhage in the nationwide inpatient sample. Neurocrit Care (2013) 0.84
Intra-arterial tenecteplase for treatment of acute ischemic stroke: feasibility and comparative outcomes. J Neuroimaging (2011) 0.84
Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke (2013) 0.84
Safety and tolerability of arundic acid in acute ischemic stroke. J Neurol Sci (2006) 0.84
A fresh twist on carotid artery dissections. Neurology (2009) 0.83
Neurologic outcomes from high risk descending thoracic and thoracoabdominal aortic operations in the era of endovascular repair. Neurocrit Care (2008) 0.83
A pilot study of darbepoetin alfa for prophylactic neuroprotection in aortic surgery. Neurocrit Care (2013) 0.83
Informed consent: the rate-limiting step in acute stroke trials. Front Neurol (2011) 0.83